Clinical Trial Detail

NCT ID NCT02418000
Title A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 Mutation
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Strategia Therapeutics
Indications

hematologic cancer

acute myeloid leukemia

bone marrow cancer

Therapies

E6201

Age Groups: adult

Additional content available in CKB BOOST